About Clinical Medicine Insights: Oncology

Latest news

 

New interview with Dr Daniela Bota

Journal newsletter sent to subscribers in week 35, 2009. Register to receive future newsletters. 

Journal newsletter sent to subscribers in week 34, 2009. Register to receive future newsletters. 

Read the Editor in Chief's latest call for papers here.

Journal newsletter sent to subscribers in week 31, 2009. Register to receive future newsletters. 

Journal newsletter sent to subscribers in week 30, 2009. Register to receive future newsletters. 

Journal newsletter sent to subscribers in week 25, 2009. Register to receive future newsletters. 

Journal newsletter sent to subscribers in week 19, 2009. Register to receive future newsletters.

Journal newsletter sent to subscribers in week 18, 2009. Register to receive future newsletters.

Follow this journal on Twitter

Journal newsletter sent to subscribers in week 16, 2009.  Register to receive future newsletters.

Journal newsletter sent to subscribers in week 13, 2009.  Register to receive future newsletters.

Journal newsletter sent to subscribers in week 10, 2009.  Register to receive future newsletters.

New call for papers sent to newsletter subscribers in week 7 2009. Readers who wish to be elligible to receive CFPs should subscribe to the newsletter.

Peer reviewers are sought. Click here to apply or to update your details.

This journal has been accepted for indexing by Elsevier's highly regarded SCOPUS index

Journal overview

 

Aims and scope:

Clinical Medicine Insights: Oncology is an international peer reviewed open access journal which publishes articles on all aspects of cancer research and treatment. Of particular interest are the following topics:

• Molecular biology
• Genetics
• Pathophysiology
• Epidemiology
• Clinical interventions
• Controlled trials
• The diagnosis and treatment of patients with cancer
• Therapeutics, pharmacology and drug delivery
• Techniques of cancer surgery

Former title:

Prior to 1/1/2010 this journal was titled Clinical Medicine: Oncology (ISSN 1177-9314.) 

Editorial standards and procedures:

Submissions, excluding editorials, letters to the editor and dedications, will be peer reviewed by two reviewers.  Reviewers are required to provide fair, balanced and constructive reports.  

Under our Fairness in Peer Review Policy authors may appeal against reviewers' recommendations which are ill-founded, unobjective or unfair.  Appeals are considered by the Editor in Chief or Associate Editor.

Papers are not sent to peer reviewers following submission of a revised manuscript. Editorial decisions on re-submitted papers are based on the author's response to the initial peer review report.

Indexing:

This journal is indexed by the following services:

• Google Scholar
• CAS
• DOAJ
• SCOPUS
• OAIster
  

SPARC Europe Seal award winner:

This journal has been awarded a SPARC Europe Seal. The Seal is an initiative of SPARC Europe (Scholarly Publishing and Academic Resources Coalition) and the Directory of Open Access Journals (DOAJ) which is awarded to journals applying a Creative Commons CC-BY copyright license and that make journal metadata accessible to DOAJ.  

Amongst other important services DOAJ makes metadata OAI-compliant.  This in turn enhances the visibility of papers and allows OAI-harvesters to include the details of journal articles in their services. We encourage readers to make use of this valuable resource.  The DOAJ search page is available here.

National Institutes of Health Public Access Policy compliant:

As of April 7 2008, the US NIH Public Access Policy requires that all peer reviewed articles resulting from research carried out with NIH funding be deposited in the Pubmed Central archive.

If you are an NIH employee or grantee Libertas Academica will ensure that you comply with the policy by depositing your paper at Pubmed Central on your behalf. 

Information for authors

 

Call for papers:

Read the Editor in Chief's latest call for papers here.

Submission types accepted: 

• Original research articles.
• Reviews: comprehensive, authoritative, descriptions of any subject within the journal's scope. They may cover basic science and clinical reviews, ethics, pro/con debates, and equipment reviews.
• Commentaries: focused and opinionated articles on any subject within the journal's scope. These articles are usually related to a contemporary issue.
• Hypotheses: articles that present an original hypothesis backed solely by previously published results rather than any new evidence. They should outline significant progress in thinking that would also be testable.
• Letters to the Editor: these can be either a re-analysis of a previously published article, or a response to such a re-analysis from the authors of the original publication.
• Methodology articles: these discuss a new experimental method, test or procedure. The article must describe a demonstrable advance on what is currently available. The method needs to have been well tested and ideally, but not necessarily, used in a way that proves its value.
• Short reports: brief reports of data from original research.
• Meeting reports: a report pertaining to activity at a meeting or conference Articles published in this journal are immediately available without delay upon publication and enjoy substantial visibility.
• Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction. Case reports must meet appropriate ethical standards.

All submissions are subject to prompt, objective and fair peer review in compliance with our Fairness in Peer Review Policy.  Copyright in published articles remains with the author(s).  Authors are continually informed of the progress of their paper and our staff are friendly and responsive. 

One author recently wrote: "I would like to say that this is the most author-friendly editing process I have experienced in over 150 publications. Thank you most sincerely."

Criteria for publication: 

Publication is dependent on peer reviewers' judgement of papers.  Reviewers are asked to provide thoughtful and unbiased feedback to authors to ensure that the conclusions of papers are valid and manuscripts achieve reasonable standards of scholarliness and intelligibility. 

Previous work in the field must be acknowledged and papers should read without unreasonable difficulty.  Papers should fit comfortably within the scope of the journal.

Reviewers are asked to act in a fair, objective and constructive manner which maintains quality standards and helps authors to communicate their research.  They are instructed that in areas of genuinely novel research issues may be raised which cannot immediately be resolved and that absolutely rigorous validation of data may therefore not be possible. 

More information on the role of peer reviewers is available on the information for reviewers page.  Where authors consider that reviewers have made recommendations which are unreasonable, unobjective or ill-founded they may appeal them to the Editor in Chief or Associate Editor under our Fairness in Peer Review Policy.

Articles submitted to other journals:

We are willing to consider papers which have been peer reviewed by other journals but not accepted for publication. 

Services for authors:

Prior to peer review of your paper we can:

• Have your paper's reference style revised to meet our requirements,
• Have your paper's English revised by specialist English-speaking technical editors.

After peer review of your paper we can:

• Have your paper revised in accordance with peer reviewer's recommendations and have a summary of responses to the reviewers created by our specialist external substantive editors,
• Provide bound reprints of your article in colour or black and white ,
• Provide online-early rapid publication if your paper prior to typesetting.

What other authors have said:

Libertas Academica actively requests, receives and acts upon feedback from authors, readers and editorial boards.  Here's what some recent authors have said about us:

"Within a couple of days the reviewers had been procured and the manuscript was out."

"The communication between your staff and me has been terrific.  Whenever progress is made with the manuscript, I receive notice.  Quite honestly, I've never had such complete communication with a journal."

"LA is different, and hopefully represents a kind of scientific publication machinery that removes the hurdles from free flow of scientific thought."

Article processing fees:

All submissions to this journal are subject to an article processing fee if they are accepted for publication.  Article processing fees are used to fund the processing of your paper and development of the journal.  Article processing fees are the only compulsory charge you will face and do not vary according to word count, page count, colour figures or any other factor.  There is no additional charge for the author(s) to make any use of their article and no charge to readers to access it.

Full fee waivers are available for authors working in undeveloped nations and partial discounts of 20-50% are available to authors in other nations.  Authors must be able to verifiably demonstrate their suitability for a discount or waiver.  Availability of waivers and discounts is subject to monthly availability and is given at the publisher's discretion.  Waivers and discounts must be applied for prior to submission.  Neither are available after submission.

Register as a peer reviewer:

Do you wish to register as a peer reviewer?  Or are you already a registered peer reviewer but you need to update your contact details?   To register or update your details visit the peer reviewer registration form. 

Applicants must be able to demonstrate at least five years of continuous experience in the journal's subject area including at least two in the previous 24 months.

Editor in Chief profile

 
Dr William Chi-shing Cho is a scientific officer at the Department of Clinical Oncology in Queen Elizabeth Hospital. His main research interests have been focusing on cancer studies utilizing high-throughput technologies to discover biomarkers for cancer diagnosis, treatment prediction and prognostication. He holds an international patent for serum biomarkers in lung cancer under the USA Patent Cooperation Treaty. He is a Chartered Scientist granted by the Science Council (UK) and a fellow member of several institutes, including the Institute of Biomedical Science (UK), Hong Kong Institute of Biomedical Science and Hong Kong Society for Molecular Diagnostic Sciences.

Dr Cho has published over 120 papers and plenty of books covering cancer biomarkers, proteomics and microRNAs. He serves as the editor-in-chief, editor and associate editor of a number of international medical journals. Dr Cho is also is a reviewer of many prestigious international journals and as an international grant reviewer of the Hope Funds for Cancer Research (USA), Cancer Research UK, Science Foundation (Ireland), National Medical Research Council (Singapore), and Academia Sinica Investigator Award (Taiwan).

>> Dr Cho's latest call for papers

Editorial Board

 
Clement Adebamowo, MD, FACS, ScD
Professor of Surgery, Director, West African Center for Bioethics and Chairman, National Health Research Ethics Committee of Nigeria (NHREC), Division of Oncology, Department of Surgery, College of Medicine, University of Ibadan, University College Hospital, Ibadan, Oyo State, Nigeria

Samuel Evans Adunyah, PhD
Chairman, Cancer Biology Division, Cancer Biology Division, Nashville, Tennessee, USA

Abass Alavi, MD
Professor of Radiology and Director, Research Education, Department of Radiology, at the Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA

Rajesh Agarwal, PhD
Professor, UCDHSC School of Pharmacy, Denver, Colorado, USA

Sophia Ananiadou, PhD
Professor, School of Computer Science, National Centre for Text Mining, Manchester Interdisciplinary Biocentre, University of Manchester, Manchester, United Kingdom

Karen Auborn, MD
Investigator, Head, Phytochemical Research Laboratory, Professor of Otolaryngology and Microbiology & Immunology, Albert Einstein College of Medicine, New York, New York, USA

You Han Bae, PhD
Professor, Department of Pharmaceutics and Pharmaceutical Chemistry, The University of Utah, Salt Lake City, Utah, USA

Giuseppe Basso, MD
Professor and Director, Laboratory of Pediatric Oncohematology, University of Padua, Italy

Charles Bennett, MD, PhD, MPP
Buehler Professor of Geriatrics and Economics Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA

Al B. Benson, MD
Professor of Medicine, Associate Director for Clinical Investigations Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Marcelo Blaya, MD
Assistant Professor of Medicine, School of Medicine, Tulane University, New Orleans, LA, USA

Daniela Bota, MD, PhD 
Assistant Professor, Department of Neurology, Neurosurgery and Hematology-Oncology, The Cancer Centre, University of California, Irvine, CA, USA

Chih-Hung Chang, PhD
Associate Professor of Medicine, Director, Methodology and Infometrics Section Buehler Center on Aging, Health & Society, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA

Gregory Cheng, MD
Professor and Head of Division, Division of Haematology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR

Daniel Chua, MD
Associate Professor and Honorary Clinical Consultant Department of Clinical Oncology Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR

Kathleen A. Cooney, MD, FACP
Professor, Departments of Internal Medicine and Urology University of Michigan Medical School Ann Arbor, MI, USA

Wendy Cozen, DO, MPH
Associate Professor of Preventive Medicine Keck School of Medicine/Norris Cancer Center University of Southern California, Los Angeles, California, USA

Tyler J Curiel, MD, MPH
Wall Distinguished Professor of Medical Oncology; Director, San Antonio Cancer Institute; Hematology and Medical Oncology, Department of Medicine, University of Texas Health Science Center at San Antonio; Scientific Director, Cancer Therapy & Treatment Center; San Antonio, Texas, USA

John F. DiPersio, MD
Chief of the Division of Bone Marrow Transplantation and Stem Cell Biology, School of Medicine, Washington University in Saint Louis, Missouri, USA

Don S. Dizon, MD, FACP
Director, Medical Oncology, Co-Director, Center for Sexuality, Intimacy, and Fertility, Program in Women’s Oncology, Women & Infants’ Hospital of Rhode Island, Assistant Professor of Obstetrics & Gynecology and Medicine, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA

David E Elder, MB, ChB
Vice Chair, Anatomic Pathology, Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA

Elana Farace, PhD
Associate Professor of Neurosurgery and Health Evaluation Sciences, Director of Clinical Research, Department of Neurosurgery, Program Leader, PSCI developing research program on Cancer Survivorship, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA

Pier Francesco Ferrucci, MD
Deputy Director of the Melanoma and Sarcoma Division, Chief of the Clinical Translational Research Programme, European Institute of Oncology, Milan, Italy

Letizia Foroni, PhD, MD, FRCPath
Consultant Clinical Scientist, Haematology, Imperial College, Hammersmith Campus, London, United Kingdom

Mike Freeman, PhD
Professor of Radiation Oncology, Vanderbilt Center for Radiation Oncology, Vanderbilt University, Nashville, Tennessee, USA

Henry S. Friedman, MD
James B. Powell, Jr., Professor of Neuro-Oncology, Professor of Pediatrics, Associate Professor of Surgery and Medicine, Assistant Professor of Pathology, Deputy Director, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina, USA

Stavros J. Gourgiotis, MD
Attending General Surgery Surgeon , 401 General Military Hospital of Athens, Greece

Thomas M. Habermann, MD
Professor of Medicine, College of Medicine, Mayo Clinic, Rochester, Minnesota, USA

K. Harish, MS, MCh
Professor and Head, Surgical Oncology, MS Ramaiah Medical College, Gokula, Bangalore, India

Stephen Hiscox, PhD
Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, Wales, UK

Elizabeth A. Holly, PhD, MPH
Professor & Chief, Division of Cancer Epidemiology, Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, California, USA

Jennifer Hu, PhD
Associate Director For Prevention and Control, Sylvester Comprehensive Cancer Center; Professor of Epidemiology and Public Health, University of Miami School of Medicine, Miami, Florida, USA

Nagraj G. Huilgol, MD
Chief Radiation Oncologist, Dr. Balabhai Nanavati Hospital, Mumbai

David Ilson, MD, PhD
Attending Physician, Associate Professor, Medicine, GI Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Rakesh Jalali, MD
Associate Professor, Tata Memorial Hospital, Mumbai, India

Michalis V. Karamouzis, MD, PhD
Assistant Professor, Department of Biological Chemistry Medical School, University of Athens,Athens, Greece

Dorothy Keefe, MD, FRACP
The Cancer Council South Australia Professor of Cancer Medicine, University of Adelaide, South Australia

David J Kerr, MD
Head of Department of Clinical Pharmacology, Rhodes Professor of Clinical Pharmacology and Cancer Therapeutics, University of Oxford, Radcliffe Infirmary, Oxford, United Kingdom

Rakesh Kumar, PhD
John G. and Marie Stella Kenedy Memorial Foundation Chair, Professor and Deputy Chairman, Department of Molecular and Cellular Oncology, Professor of Biochemistry & Molecular Biology, Professor- Graduate School of Biological Sciences at UT Houston, Professor- Molecular & Cellular Biology, Baylor College of Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA

Dora Kwong, MD
Associate Professor, Department of Clinical Oncology, the University of Hong Kong, Queen Mary Hospital, Hong Kong, SAR

Alshad S. Lalani, PhD
Associate Director, Translational Medicine, Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA

Francesco Lo-Coco, MD
Professor of Hematology, Dipartimento di Biopatologia e Diagnostica per Immagini, Universita' Tor Vergata, Rome, Italy

Wlodzimierz Luczynski, MD
Department of Pediatric Oncology, Medical University of Bialystok, Poland

Tarun K. Mandal, PhD
McCaffrey/Norwood Professor of Pharmacy, Professor of Pharmaceutics, Xavier University of Louisiana, Adjunct Professor of Genetics and Gene Therapy, Louisiana State University Health Sciences Center, New Orleans, Louisiana, Adjunct Professor of Pharmaceutical Sciences, The University of Tennessee Health Sciences Center, Memphis, Tennessee, USA

Malcolm Mason, MD
Cancer Research Wales Professor of Clinical Oncology, Head of Department of Oncology & Palliative Medicine, Cardiff University, Cardiff, Wales

Luisa Massimo, PhD, MD
Professor Emeritus in Pediatrics of the “G.Gaslini” Scientific Children’s Hospital of Genova, Genova, Italy

Vidya Nallasura, MS
Medical Scientist, The University of Chicago, Chicago, IL 60637-5418, USA.

Andrea Nicolini, MD
Clinical Researcher, Department of Internal Medicine, University of Pisa, Pisa, Italy

Shuming Nie, PhD
Wallace H. Coulter Distinguished Chair in Biomedical Engineering Director of Emory-Georgia Tech Cancer Nanotechnology Center Professor of Biomedical Engineering, Chemistry, Hematology/Oncology, and Materials Science and Engineering Emory University and Georgia Institute of Technology, Atlanta, Georgia, USA

Kjell Öberg, MD
Professor Endocrine Oncology, Dean of the Medical Faculty, Professor of Endocrine Oncology, Uppsala University, University Hospital, Uppsala, Sweden

Funmi Olopade, MD
Walter L. Palmer Distinguished Service Professor in Medicine and Human Genetics; Director, Hematology/Oncology Fellowship Program; Director, Center for Clinical Cancer Genetics, University of Chicago, Chicago, Illinois, USA

Steve Passik, PhD
Walther VIP, Clinical Science, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Pier Paolo Piccaluga, MD
Istituto di Ematologia e Oncologia Medica "L. e A. Seràgnoli" Università degli Studi di Bologna, Bologna, Italy

Pat Price, MD
Ralston Paterson Professor of Radiation Oncology, Academic Radiation Oncology, Division of Cancer Studies, Faculty of Medical and Human Sciences, University of Manchester, Christie Hospital NHS Trust, Manchester, United Kingdom

M. Wasif Saif, MD, MBBS
Associate Professor of Medicine, Director, GI Oncology Group, Yale University School of Medicine, New Haven, Connecticut, USA

Richard Schilsky, MD
Professor of Medicine, Associate Dean for Clinical Research, Biological Sciences Division, University of Chicago, Chicago, Illinois, USA

Laura A. Siminoff, PhD
Professor and Chair, Department of Social and Behavioral Health, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA

Daniele Santini, MD
Assistant Professor in General Pathology, Department of Oncology, University Campus Bio-Medico, Rome, Italy

Miguel A. Sanz, MD
Associate Professor of Medicine, Chief of Hematology Service and Stem Cell Transplant Unit, University Hospital La Fe, Valencia, Spain

Michael A. Tainsky, PhD
Barbara & Fred Erb Professor of Cancer Genetics Department of Pathology Director, Program in Molecular Biology and Genetics Karmanos Cancer Institute Wayne State University School of Medicine, Detroit, Michigan, USA

Celalettin Ustun, MD
Assistant Professor of Medicine, Medical College of Georgia, Department of Medicine, Section of Hematology/Oncology and Bone Marrow Transplantation, Augusta, GA, USA

Bruno Vincenzi, MD
Medical Oncology, Campus Bio-Medico University, Rome, Italy

Vincent Vinciguerra, MD
Professor of Medicine, New York University School of Medicine, Chief, Don Monti Division of Medical Oncology/Division of Hematology, North Shore University Hospital, Great Neck, New York, USA

Jan Walewski, MD
MSCM Institute and Cancer Centre, Warsaw, Poland

Patrick Y. Wen, MD
Clinical Director, Center For Neuro-Oncology, Dana Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA

Alice S. Whittemore, PhD
Professor of Epidemiology and Biostatistics Division of Epidemiology, Stanford University School of Medicine, Stanford, California, USA

Peter Wiernik, PhD
Founding Editor in Chief, Clinical: Medicine Oncology. Director, Comprehensive Cancer Centre of Our Lady of Mercy Medical Centre, New York Medical College, New York, and Professor of Medicine and Radiation Oncology, New York Medical College, Valhalla, New York, USA

Gutian Xiao, PhD
Associate Professor, Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA

Xiao-Feng Yang, MD, PhD
Associate Professor, Department of Pharmacology, School of Medicine, Temple University, Philadelphia, Pennsylvania, USA

Anas Younes, MD
Professor of Medicine, Director, Clinical and Translational Research Department of Lymphoma/Myeloma, MD Anderson Cancer Centre, Houston, Texas, USA

H.A. Zaren, MD
Professor, Department of Surgical Oncology, University of Illinois at Chicago, Chicago, Illinois, USA

Benny Chung-Ying Zee, PhD
Professor and Director, Centre for Clinical Trials, School of Public Health, the Chinese University of Hong Kong

 

Related journals